p38 MAP p38 MAP kinase inhibitor compounds for the prophylaxis and treatment of adhesion process

摘要

The present invention relates to the structures of types (I) - (VII) which can be used for pharmacy, clinical and experimental medicine and veterinary medicine and fields, Which is associated with a novel inhibitory compound of p38 MAP kinase. The present invention discloses pharmaceutical compositions comprising an effective amount of SB203580 material or one or combination of the compounds of types (I) - (VII) and a pharmaceutically acceptable carrier, diluent or excipient. It also discloses the use of SB203580 substance as an agent with anti-adhesion properties. It also discloses methods for the prevention and treatment of diseases or conditions that may omit additional administration of prepared materials within the post-operative period and which may result in adherence formation and growth.